Embedded Files
The Brother Lucian Blersch Endowment and the School of Natural Sciences at St. Edward's University presents
Global health refers to health problems, such as infectious and insect-borne diseases, that can spread from one country to another, transcending frontiers. In an increasingly connected world, diseases can move as freely as people and products. Infectious diseases (such as SARS, avian flu and drug-resistant TB) can easily cross national borders. Indirectly, rising incidences of diseases like HIV/AIDS, malaria and TB are increasing poverty and political instability in many countries, with political and economic consequences worldwide. Working to address global health problems can help prevent civil conflict in some countries. It can support economic stability and improve the quality of people’s lives, which benefit both global security and the economy.
The majority of the world’s health care resources are spent on diseases that affect 10% of the world’s population. Malaria, TB, diarrheal diseases and pneumonia account for 21% of all human illness worldwide, yet they receive 0.31% of all funds devoted to research. Working to solve global health problems will help ensure that resources are distributed more fairly across the globe.
Science and global institutions can align in many ways to improve global health. This event’s objective is to celebrate scientists, policymakers, practitioners, communities and philanthropists whose initiatives offer effective approaches to advancing global health, as well as to present some of the latest developments in the field.
Speakers
Eamonn F. Healy is the Brother Lucian Blersch Professor of Science and Professor of Chemistry at St. Edward’s University. His current research focuses on the design of structure-activity probes to elucidate enzymatic activity. The interdisciplinary approach includes molecular modeling for the simulation of inhibitor binding, overexpression of the target proteins and in vitro assays of enzymatic activity and inhibition. Targets include HIV-1 integrase, the c-Kit and src-abl proteins, and the metalloproteinases associated with CXCL16 shedding. Dr. Healy received his doctorate in chemistry from the University of Texas at Austin.
Lary Walker is a research professor of Neuroscience at Emory University. Research in his lab is focused on understanding the origins of Alzheimer’s disease (AD) and other neurodegenerative diseases. Dr. Walker is particularly interested in the characteristics of Alzheimer-associated proteins in the brains of humans and nonhuman primates and why only humans are susceptible to AD. He and his lab team are also interested in how aging affects the cerebral vascular system and how these changes contribute to age-associated cognitive decline. Dr. Walker received his doctorate from Tulane University.
Neil Cashman is a professor of Medicine and the Canada Research Chair in the Brain Research Center at the University of British Columbia. Dr. Cashman is a neurologist-neuroscientist working in neurodegeneration and neuroimmunology, specializing in amyloid encephalopathies such as the prion illnesse, Alzheimer’s disease and motor neuron diseases, particularly amyotrophic lateral sclerosis. He serves as scientific director to PrioNet Canada, one of the Networks of Centres of Excellence of Canada, which is focused on basic and applied research in the transmissible spongiform encephalopathies. He is founder and Chief Scientific Officer of Amorfix Life Sciences. Dr. Cashman earned his MD at the University of Massachusetts Medical School.
Simonetta Sipione is an assistant professor of Pharmacology and a Canada Research Chair in the Neurobiology of Huntington’s Disease (HD) at the University of Alberta. Dr. Sipione’s research is directed toward the understanding of the molecular mechanisms underlying HD. Projects in her laboratory are mainly focused on understanding the effects of brain lipid dysregulation on function and survival of HD neurons, and on identifying the underlying mechanisms and potential therapeutic treatments. Dr. Sipione received her PhD in Biochemistry from the University of Catania, Italy.
Kira Fortune has worked more than 10 years in Africa, Asia, Europe and Latin America in public health, gender and social determinants of health. The institutions where she has worked include the International Planned Parenthood Federation in London and UNICEF where she was responsible for the program on Prevention of Mother to Child Transmission of HIV in Tanzania. Fortune has extensive experience working with NGOs, academia as well as in inter-governmental organizations. Prior to moving to Washington DC, she was responsible for the International Health Research Network in Denmark with the objective of translating research evidence into policy. In 2008, she joined the Pan-American Health Organization, the regional office of the UN’s World Health Organization, where she is responsible for the social determinants of health. Fortune holds a Master’s degree as well as a Doctorate in Sociology from University of London. She also holds a Master’s degree in International Public Health from Copenhagen University.
Elizabeth D. Gibbons is a Distinguished Fellow at the Kozmetsky Center of Excellence in Global Finance at St. Edward’s University, and she is a Visiting Scientist at the FXB Center for Health and Human Rights in the Harvard School of Public Health. Gibbons enjoyed a lengthy and distinguished career in the United Nations Children’s Fund (UNICEF). Her career in social development and humanitarian affairs has spanned more than three decades, during which she lived and worked in Togo, Kenya, Zimbabwe, Haiti and Guatemala. She served as strategic regional advisor to UNICEF’s Haiti operations following the devastating earthquake of 2010. A graduate of Smith College and Columbia University, Gibbons is the author of Sanctions in Haiti: Human Rights and Democracy under Assault.
Page updated
Report abuse